# Early Phase Clinical Research Support

> **NIH NIH P30** · UNIVERSITY OF KANSAS MEDICAL CENTER · 2020 · $60,049

## Abstract

Early Phase Clinical Research Support – Project Summary 
This renewal is the first time that KUCC is requesting Early Phase Clinical Research Support (EPCRS) funds 
and undergoing formal evaluation as a CCSG component. Although this is the first year to request CCSG 
support, KUCC has been investing heavily to build the infrastructure, facilities, staffing and capabilities for a 
successful early phase clinical research program. Stephen Williamson, MD, leads the Early Phase Clinical 
Research program. 
Long-range strategic planning is focused on short-term, pilot (pre-phase I) and phase I clinical research studies 
originating from KUCC scientific investigators. Preliminary data generated from these studies are typically 
challenged by shortages in funding, yet have great potential to serve as the foundation for later phase studies 
through competitive grants or industry. 
The Investigator-Initiated Trial Steering Committee will score and prioritize proposed studies for EPCRS 
funding based on whether the new compound was invented by a KUCC member, a repurposed drug with 
KUCC pre-clinical data and highly likely to provide preliminary data for further clinical development. 
In order to be considered, the proposals requesting EPCRS funds must be: 1) high priority, innovative, pilot 
and phase 0 or I institutional clinical studies focusing on initial testing of a candidate agent or device for the 
diagnosis, prevention, detection or treatment of cancer; 2) conceptualized/designed by KUCC members; and 
3) of short duration (e.g., 1-2 years). If the proposal is selected for EPCR support, the Protocol Review and 
Monitoring System must approve the study before funding will be released.

## Key facts

- **NIH application ID:** 9975741
- **Project number:** 5P30CA168524-09
- **Recipient organization:** UNIVERSITY OF KANSAS MEDICAL CENTER
- **Principal Investigator:** Joaquina C Baranda
- **Activity code:** P30 (R01, R21, SBIR, etc.)
- **Funding institute:** NIH
- **Fiscal year:** 2020
- **Award amount:** $60,049
- **Award type:** 5
- **Project period:** 2012-07-11 → 2022-06-30

## Primary source

NIH RePORTER: https://reporter.nih.gov/project-details/9975741

## Citation

> US National Institutes of Health, RePORTER application 9975741, Early Phase Clinical Research Support (5P30CA168524-09). Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/grant/nih/9975741. Licensed CC0.

---

*[NIH grants dataset](/datasets/nih-grants) · CC0 1.0*